69 results
Page 2 of 4
8-K
EX-99.2
d6o1cwk0ibey9 36wgq
8 Jan 24
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
8:21am
424B3
3qd8kla
19 Dec 23
Prospectus supplement
4:36pm
F-3
EX-1.2
bmjyo1w4p njr
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
wvh 99ikfs3mepdsue4
7 Dec 23
Shelf registration (foreign)
4:16pm
6-K
EX-99.1
zs6bpcpph
25 Sep 23
Current report (foreign)
8:10am
6-K
EX-99.1
itd48kfh qrpqjqy42ea
28 Aug 23
Current report (foreign)
4:16pm
424B3
2vuvuz7
15 Aug 23
Prospectus supplement
4:52pm
6-K
EX-99.2
y7uuk
14 Aug 23
NewAmsterdam Pharma Announces Appointment of William “BJ” Jones, formerly of Biohaven Pharmaceuticals, as Chief Commercial Officer
4:52pm
POS AM
81wugakhaky k3egof
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.1
ca86imeffhpamuy
7 Aug 23
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights
7:38am
6-K
EX-99.1
c3hd6vohdj 5gd7q
7 Aug 23
Research and development expenses
7:24am
6-K
EX-99.2
qo8 t3wr67dbh2
7 Aug 23
Research and development expenses
7:24am
424B3
0ycoq0gj5l4uc86 iz
9 Jun 23
Prospectus supplement
9:43pm
6-K
EX-1.1
i62f ziy7
9 Jun 23
Current report (foreign)
9:39pm
6-K
EX-99.1
55g3gmr9
9 Jun 23
Current report (foreign)
9:39pm
424B3
hj89h k4r
8 Jun 23
Prospectus supplement
5:01pm
424B3
k39vi
6 Jun 23
Prospectus supplement
4:20pm
6-K
EX-99.3
a7f4phy9ni0lz 4s7ftp
5 Jun 23
Current report (foreign)
8:50am
424B3
1fq32zee3mmg
25 Apr 23
Prospectus supplement
8:14am
POS AM
e240dd8moakedvq
17 Apr 23
Prospectus update (post-effective amendment)
9:09am